soul trial oral semaglutide cardiovascular outcomes 2025 benefit study in High-Risk Type 2 Diabetes: Confirmed in the Trial Scorecard: SOUL – Oral Semaglutide in High-Risk Type – soul trial oral semaglutide cardiovascular

Osteoarthritis burden and inequality from 1990 to 2021: a systematic analysis for the global burden of disease Study 2021

Using a semaglutide reconstitution calculator If the math in this guide feels overwhelming, you are not alone

Who Should Consider GLP-1 Therapy and the Role of Genetic Context GLP-1 therapy applies to adults with BMI 30 kg/m or 27 with weight-related conditions, or those with type 2 diabetes

AJ: Writing original draft, Writing review & editing

A common pattern (exact brands and steps vary): Semaglutide: start low for 4 weeks, then step up every 4+ weeks toward a target dose if tolerated

Appetite suppression from the medication makes it harder to eat enough protein at exactly the moment more protein is needed